Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers
Public ClinicalTrials.gov record NCT03471078. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Placebo-Controlled Study With Open-Label Extension to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Active Non-Hematological Cancers
Study identification
- NCT ID
- NCT03471078
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sobi, Inc.
- Industry
- Enrollment
- 122 participants
Conditions and interventions
Conditions
Interventions
- Avatrombopag Drug
- Placebo Oral Tablet Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 11, 2018
- Primary completion
- Aug 27, 2020
- Completion
- Jan 30, 2023
- Last update posted
- Sep 27, 2023
2018 – 2023
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dova Site | Anaheim | California | 92801 | — |
| Dova Site | Bakersfield | California | 93309 | — |
| Dova Site | Riverside | California | 92501 | — |
| Dova Site | Santa Monica | California | 90403 | — |
| Dova Site | Augusta | Georgia | 30912 | — |
| Dova Site | Harvey | Illinois | 60426 | — |
| Dova Site | Skokie | Illinois | 60076 | — |
| Dova Site | Bloomington | Indiana | 47403 | — |
| Dova Site | Wichita | Kansas | 67214 | — |
| Dova Site | Ashland | Kentucky | 41101 | — |
| Dova Site | Boston | Massachusetts | 02114 | — |
| Dova Site | Minneapolis | Minnesota | 55417 | — |
| Dova Site | Canton | Ohio | 44718 | — |
| Dova Site | Gettysburg | Pennsylvania | 17325 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03471078, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2023 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03471078 live on ClinicalTrials.gov.